Charles Goulding, Attorney/CPA, is the President of Energy Tax Savers, Inc., an interdisciplinary tax and engineering firm that specializes in the energy-efficient aspects of buildings.
Andressa Bonafe is an Analyst with Energy Tax Savers, Inc.
Charles G. Goulding is a Senior Analyst with Energy Tax Savers, Inc.
Center for Disease Control and Prevention Press Release, Number of Americans with Diabetes Projected to Double or Triple by 2050, Oct. 22, 2010. Available online at http://www.cdc.gov/media/pressrel/2010/r101022.html
Charles R. Goulding, Charles G. Goulding and Raymond Kumar, R&D Tax Credit Aspects of Human Body Weight, CORP. Bus. TAX’N MONTHLY, December 2012, at 9.
Fierce Biotech, Top diabetes drug pipelines of 2012, available online at http://www.fiercebiotech.com/special-reports/top-diabetes-drug-pipelines-2012
For more information see http://www.lilly.com/research-development/approach/Pages/approach-to-rd.aspx
For more information see http://www.novonordisk.com/science/rd-sites/t1d-r-and-d-center.asp
Wayne Koberstein, The Race in Diabetes R&D, Feb. 2013. Available online athttp://lifescienceleader.com/blogs/contributing-editors-2/item/4411-the-race-in-diabetes-rd
NYTimes, F.D.A. to Restrict Avandia, Citing Heart Risk, September 23, 2012. Available online athttp://www.nytimes.com/2010/09/24/health/policy/24avandia.html?_r=0
The Wall Street Journal, FDA Rebuffs Insulin Drug, Feb. 12, 2013. Available online athttp://online.wsj.com/article/SB10001424127887324880504578297401171942788.html
Fierce Pharma, AZ, BMS create “Diabetes Inc”, combine marketing in new home, Feb. 1, 2013. Available online athttp://www.fiercepharma.com/story/az-bms-create-diabetes-inc-combine-marketing-new-home/2013-02-01
PMLive, Lilly opens diabetes R&D center in Shangai, June 1, 2012. Available online athttp://www.pmlive.com/pharma_news/lilly_china_shanghai_diabetes_research_centre_406271
